Literature DB >> 24472032

Understanding the experience of caring for children with haemophilia: cross-sectional study of caregivers in the United States.

M DeKoven1, S Karkare, L A Kelley, D L Cooper, H Pham, J Powers, W C Lee, T Wisniewski.   

Abstract

Congenital haemophilia is an inherited bleeding disorder typically diagnosed at birth or shortly thereafter. Haemophilia imposes a significant burden on patients and their caregivers. The aim of the study was to quantify the overall burden of haemophilia on caregivers in the USA using a novel disease-specific questionnaire and the previously validated CarerQol. Targeted literature review and a previous survey conducted by the authors was used to develop an online questionnaire with six burden domains of interest to caregivers (emotional stress, financial, sacrifice, medical management, child's pain and transportation) and several visual analogue scales (VAS). Content validity of the questionnaire was confirmed by three haemophilia caregivers. The study sample consisted of caregivers of children with haemophilia identified via a previously developed opt-in research database. Descriptive statistics were employed for demographic and clinical characteristics; a generalized linear model (GLM) was used to identify factors influencing caregiver burden. A total of 310 caregivers completed the survey (45.5% response rate). Most of the participating caregivers were mothers of a child with haemophilia (88%), between 35 and 44 years of age (48%), and with a college education or a postgraduate degree (63%). 'Child's pain' was identified as the most burdensome domain to caregivers (median score = 3.50 out of 5), followed by 'emotional stress' (2.67), 'financial' (2.40), 'transportation' (2.33), 'sacrifice' (2.17) and 'medical management' (2.00) domains. Although higher income exhibited a protective effect, episodes of bleeds, current presence of an inhibitor and lower caregiver productivity in the past month negatively affected caregiver burden per GLM results. Training and educational programs should potentially be developed to address caregiver burden.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  burden; caregiver; emotional stress; haemophilia; pain; quality of life

Mesh:

Year:  2014        PMID: 24472032     DOI: 10.1111/hae.12379

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  10 in total

1.  Supporting caregivers during hematopoietic cell transplantation for children with primary immunodeficiency disorders.

Authors:  Jennie Yoo; Meghan C Halley; E Anne Lown; Veronica Yank; Katherine Ort; Morton J Cowan; Morna J Dorsey; Heather Smith; Sumathi Iyengar; Christopher Scalchunes; Christina Mangurian
Journal:  J Allergy Clin Immunol       Date:  2018-10-25       Impact factor: 10.793

Review 2.  The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countries.

Authors:  Fadi Nossair; Courtney D Thornburg
Journal:  Ther Adv Hematol       Date:  2018-07-02

3.  Measuring hemophilia caregiver burden: validation of the Hemophilia Caregiver Impact measure.

Authors:  Carolyn E Schwartz; Victoria E Powell; Adi Eldar-Lissai
Journal:  Qual Life Res       Date:  2017-04-25       Impact factor: 4.147

Review 4.  Hemophilia Care in the Pediatric Age.

Authors:  Marta Bertamino; Francesca Riccardi; Laura Banov; Johanna Svahn; Angelo Claudio Molinari
Journal:  J Clin Med       Date:  2017-05-19       Impact factor: 4.241

Review 5.  The experiences and attitudes of hemophilia carriers around pregnancy: A qualitative systematic review.

Authors:  Marieke C Punt; Tanja H Aalders; Kitty W M Bloemenkamp; Mariette H E Driessens; Kathelijn Fischer; Marlies H Schrijvers; Karin P M van Galen
Journal:  J Thromb Haemost       Date:  2020-05-12       Impact factor: 5.824

6.  Health-related quality of life in paediatric haemophilia B patients treated with rIX-FP.

Authors:  Sylvia von Mackensen; Jinesh Shah; Wilfried Seifert; Gili Kenet
Journal:  Haemophilia       Date:  2018-11-14       Impact factor: 4.287

7.  Real-world evidence on Kovaltry (81-8973) in children with moderate or severe hemophilia A in Europe: a nested cohort analysis.

Authors:  Jamie O'Hara; Ceri Hirst; Jose Francisco Cabre Marquez; Tom Burke
Journal:  Orphanet J Rare Dis       Date:  2021-01-15       Impact factor: 4.123

8.  AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors.

Authors:  Tadashi Matsushita; Nobuaki Suzuki; Azusa Nagao; Chiai Nagae; Haruko Yamaguchi-Suita; Yui Kyogoku; Akiko Ioka; Keiji Nogami
Journal:  BMJ Open       Date:  2022-03-14       Impact factor: 2.692

9.  Health-related quality of life, developmental milestones, and self-esteem in young adults with bleeding disorders.

Authors:  P F Limperg; L Haverman; H Maurice-Stam; M Coppens; C Valk; M J H A Kruip; J Eikenboom; M Peters; M A Grootenhuis
Journal:  Qual Life Res       Date:  2017-09-12       Impact factor: 4.147

10.  The impact of extended half-life versus conventional factor product on hemophilia caregiver burden.

Authors:  Carolyn E Schwartz; Victoria E Powell; Jun Su; Jie Zhang; Adi Eldar-Lissai
Journal:  Qual Life Res       Date:  2018-02-01       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.